A community-based study of acne-related health preferences in adolescents

Archives of Dermatology

Volumn 144, Issue 8, 2008, Pages 988-994

  Chen, Cynthia L ^a   Kuppermann, Miriam ^a   Caughey, Aaron B ^a   Zane, Lee T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; ADOLESCENCE; ADOLESCENT; ARTICLE; COMMUNITY ASSESSMENT; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HIGH SCHOOL; HUMAN; INCOME; INSTRUMENTATION; MAJOR CLINICAL STUDY; MALE; METRIC SYSTEM; PHYSICIAN; PRIORITY JOURNAL; RANK SUM TEST; RATING SCALE; RECURRENT DISEASE; SCAR; SCORING SYSTEM; STATISTICAL ANALYSIS; UNIVARIATE ANALYSIS; VOLUNTEER;

ACNE VULGARIS; ADOLESCENT; ADOLESCENT PSYCHOLOGY; CICATRIX; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; DECISION MAKING; FEMALE; HUMANS; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; PARENTS; PATIENT SATISFACTION; PHYSICIANS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; STATISTICS, NONPARAMETRIC;

EID: 49949098352     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.8.988     Document Type: Article

References (45)

1. Webster GF. Acne vulgaris. BMJ. 2002;325(7362):475-479.
2. White GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol. 1998;39(2, pt 3):S34-S37.
3. Sulzberger MB, Zaidems SH. Psychogenic factors in dermatological disorders. Med Clin North Am. 1948;32:669-685.
4. Kremer MM. Psychological impact of acne in adolescence. J Am Med Womens Assoc. 1969;24(4):303-305.
5. Cunliffe WJ. Acne and unemployment. Br J Dermatol. 1986;115(3):386.
6. Aktan S, Ozmen E, Sanli B. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol. 2000;39(5):354-357.
7. Tan JK. Psychosocial impact of acne vulgaris: evaluating the evidence. Skin Therapy Lett. 2004;9(7):1-3, 9.
8. Yazici K, Baz K, Yazici AE, et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol. 2004;18(4):435-439.
9. van der Meeren HL, van der Schaar WW, van den Hurk CM. The psychological impact of severe acne. Cutis. 1985;36(1):84-86.
10. Berson DS, Chalker DK, Harper JC, Leyden JJ, Shalita AR, Webster GF. Current concepts in the treatment of acne: report from a clinical roundtable. Cutis. 2003;72(1)(suppl):5-13.
11. Koo J. The psychosocial impact of acne: patients' perceptions. J Am Acad Dermatol. 1995;32(5, pt 3):S26-S30.
12. Smith JA. The impact of skin disease on the quality of life of adolescents. Adolesc Med. 2001;12(2):vii, 343-353.
13. Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140(4):672-676.
14. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139(5):846-850.
15. Klassen AF, Newton JN, Mallon E. Measuring quality of life in people referred for specialist care of acne. J Am Acad Dermatol. 2000;43(2, pt 1):229-233.
16. Kilkenny M, Stathakis V, Hibbert ME, Patton G, Caust J, Bowes G. Acne in Victorian adolescents. J Paediatr Child Health. 1997;33(5):430-433.
17. Yeung CK, Teo LH, Xiang LH, Chan HH. A community-based epidemiological study of acne vulgaris in Hong Kong adolescents. Acta Derm Venereol. 2002;82(2):104-107.
18. Smithard A, Glazebrook C, Williams HC. Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study. Br J Dermatol. 2001;145(2):274-279.
19. Froberg DG, Kane RL. Methodology for measuring health-state preferences, I: measurement strategies. J Clin Epidemiol. 1989;42(4):345-354.
20. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res. 1972;7(2):118-133.
21. US Department of Health and Human Services (DHHS), Food and Drug Administration (FDA), Center for Drug Evaluation and Research. Guidance for industry: acne vulgaris: developing drugs for treatment: draft guidance. FDA Web site. http://www.fda.gov/cder/Guidance/6499dft.pdf. Accessed June 1, 2006.
22. Arias E. United States Life Tables, 2002. Vol. 53. Hyattsville, MD: National Center for Health Statistics; 2004.
23. Torrance GW, Boyle MH, Horwood SP. Application of multi-attribute utility theory to measure social preferences for health states. Oper Res. 1982;30(6):1043-1069.
24. Martin AR, Lookingbill DP, Botek A, Light J, Thiboutot D, Girman CJ. Health-related quality of life among patients with facial acne: assessment of a new acne-specific questionnaire. Clin Exp Dermatol. 2001;26(5):380-385.
25. Saigal S, Stoskopf BL, Feeny D, et al. Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents. JAMA. 1999;281(21):1991-1997.
26. Chen SC, Bayoumi AM, Soon SL, et al. A catalog of dermatology utilities. J Investig Dermatol Symp Proc. 2004;9(2):160-168.
27. Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB. Designing Clinical Research. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001.
28. Davison A, Hinkley D. Bootstrap Methods and Their Application. Cambridge, England: Cambridge University Press; 1997.
29. Mittmann N, Trakas K, Risebrough N, Liu BA. Utility scores for chronic conditions in a community-dwelling population. Pharmacoeconomics. 1999;15(4):369-376.
30. Nease RF Jr, Kneeland T, O'Connor GT, et al; Ischemic Heart Disease Patient Outcomes Research Team. Variation in patient utilities for outcomes of the management of chronic stable angina. JAMA. 1995;273(15):1185-1190.
31. Stavem K. Quality of life in epilepsy. Epilepsy Res. 1998;29(3):201-209.
32. Saw SM, Gazzard G, Au Eong KG, Koh D. Utility values and myopia in teenage school students. Br J Ophthalmol. 2003;87(3):341-345.
33. Kuppermann M, Nease RF, Learman LA, Gates E, Blumberg B, Washington AE. Procedure-related miscarriages and Down syndrome-affected births. Obstet Gynecol. 2000;96(4):511-516.
34. Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol. 1989;14(3):194-198.
35. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107(5):707-713.
36. Morgan M, McCreedy R, Simpson J, Hay RJ. Dermatology quality of life scales-a measure of the impact of skin diseases. Br J Dermatol. 1997;136(2):202-206.
37. Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol. 1997;37(1):41-50.
38. Ozolins M, Eady EA, Avery AJ, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet. 2004;364(9452):2188- 2195.
39. Thiboutot D, Pariser DM, Egan N, et al. Adapalene gel 0.3% for the treatment of acne vulgaris. J Am Acad Dermatol. 2006;54(2):242-250.
40. Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994;19(4):303-308.
41. Niemeier V, Kupfer J, Demmelbauer-Ebner M, Stangier U, Effendy I, Gieler U. Coping with acne vulgaris. Dermatology. 1998;196(1):108-115.
42. Mulder MM, Sigurdsson V, van Zuuren EJ, et al. Psychosocial impact of acne vulgaris. Dermatology. 2001;203(2):124-130.
43. Ross PL, Littenberg B, Fearn P, Scardino PT, Karakiewicz PI, Kattan MW. Paper standard gamble: a paper-based measure of standard gamble utility for current health. Int J Technol Assess Health Care. 2003;19(1):135-147.
44. Albertsen PC, Nease RF Jr, Potosky AL. Assessment of patient preferences among men with prostate cancer. J Urol. 1998;159(1):158-163.
45. San Francisco Unified School District. School Site List & Summary: Spring Snapshot, March 1, 2006. San Francisco, CA: San Francisco Unified School District; 2006.